Bennett Levitan
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Environmental Valuation
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 25
- Pharmaceutical Economics and Policy 7
- Economic and Environmental Valuation 6
- Pharmacology 13
- Pharmaceutical industry and healthcare 13
- Co-authors
- Esther W. de Bekker‐Grob (11 shared papers)Stuart Kauffman (2 shared papers)Juhaeri Juhaeri (9 shared papers)Chiara Whichello (9 shared papers)Jorien Veldwijk (9 shared papers)Žhong Yuan (18 shared papers)Isabelle Huys (8 shared papers)Brett Hauber (12 shared papers)
- Journals
- Value in Health (11 papers)Therapeutic Innovation & Regulatory Science (6 papers)Patient (5 papers)Frontiers in Pharmacology (3 papers)Circulation (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Bennett Levitan
84 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 122
- Internal Medicine 107
- Economics and Econometrics 359
- Toxicology 35
- General Decision Sciences 20
- Pharmacology 78
Countries citing papers authored by Bennett Levitan
This map shows the geographic impact of Bennett Levitan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bennett Levitan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bennett Levitan more than expected).
Fields of papers citing papers by Bennett Levitan
This network shows the impact of papers produced by Bennett Levitan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bennett Levitan. The network helps show where Bennett Levitan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bennett Levitan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 110 | |
| 2 | 2017 | 104 | |
| 3 | 2016 | 101 | |
| 4 | 2018 | 73 | |
| 5 | 1998 | 59 | |
| 6 | 2019 | 56 | |
| 7 | 1995 | 56 | |
| 8 | 2019 | 48 | |
| 9 | 2019 | 38 | |
| 10 | 2015 | 35 | |
| 11 | 2020 | 33 | |
| 12 | 2013 | 30 | |
| 13 | 2016 | 29 | |
| 14 | 2014 | 28 | |
| 15 | 2016 | 27 | |
| 16 | 2015 | 26 | |
| 17 | 2014 | 25 | |
| 18 | 2020 | 24 | |
| 19 | 2015 | 22 | |
| 20 | 2016 | 22 |
About Bennett Levitan
Bennett Levitan is a scholar working on Economics and Econometrics, Pharmacology, Cardiology and Cardiovascular Medicine, Internal Medicine and General Health Professions, having authored 84 papers that have together received 1.4k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Pharmaceutical industry and healthcare (13 papers), Atrial Fibrillation Management and Outcomes (8 papers), Venous Thromboembolism Diagnosis and Management (8 papers), Pharmaceutical Economics and Policy (7 papers), Economic and Environmental Valuation (6 papers), Schizophrenia research and treatment (5 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Internal Medicine (107 citations), Economics and Econometrics (359 citations), Toxicology (35 citations), General Decision Sciences (20 citations) and Pharmacology (78 citations). Bennett Levitan has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Esther W. de Bekker‐Grob, Stuart Kauffman, Juhaeri Juhaeri, Chiara Whichello, Jorien Veldwijk, Žhong Yuan, Isabelle Huys, Brett Hauber, Eline van Overbeeke and Martin Ho. Their work appears in journals such as Value in Health, Therapeutic Innovation & Regulatory Science, Patient, Frontiers in Pharmacology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.